期刊文献+

TIMP-1 Production in Human Retinal Pigment Epithelial Cells after Laser Exposure

TIMP-1 Production in Human Retinal Pigment Epithelial Cells after Laser Exposure
下载PDF
导出
摘要 Purpose: To investigate changes in the production of tissue inhibitor of metalloproteinase type 1 (TIMP-1) by human retinal pigment epithelial (RPE) cells following argon laser exposure.Methods: Human cultured ARPE19 cells were exposed to argon green laser at four different energy levels ranging from 60mW to 360mW. After laser exposure, the culture media were sampled at 0, 24, 72 and 144 hours for TIMP-1 concentration produced by the RPE cells. The levels of TIMP-1 in the cells treated with different laser energy levels were compared with a control group not exposed to laser application.Immunocytochemistry for proliferating cell nuclear antigen (PCNA) was performed to detect any adverse effects on the RPE cells caused by laser exposure.Results: Immediately after laser exposure, the concentration of TIMP- 1 was not detectable. At 24 hours after laser exposure, the concentration of TIMP-1 increased significantly in RPE cells treated with 120mW and 240mW at 24 hours (P=0.006 and P=0.001respectively) compared with control cells. At 72 hours after treatment, RPE cells treated at 120mW, 240mW and 360mW demonstrated significantly increase in TIMP-1production compared with control (P=0.003, P < 0.001 and P < 0.001, respectively).No significant reduction in cell viability was observed following laser application as detected by PCNA expression.Conclusions: Our results demonstrated that early TIMP-1 production by RPE cells in cell cultures was enhanced following laser exposure. Purpose: To investigate changes in the production of tissue inhibitor of metalloproteinase type 1 (TIMP-1) by human retinal pigment epithelial (RPE) cells following argon laser exposure. Methods: Human cultured ARPE19 cells were exposed to argon green laser at four different energy levels ranging from 60mW to 360mW. After laser exposure, the culture media were sampled at 0, 24, 72 and 144 hours for TIMP-1 concentration produced by the RPE cells. The levels of TIMP-1 in the cells treated with different laser energy levels were compared with a control group not exposed to laser application. Immunocytochemistry for proliferating cell nuclear antigen (PCNA) was performed to detect any adverse effects on the RPE cells caused by laser exposure. Results: Immediately after laser exposure, the concentration of TIMP-1 was not detectable. At 24 hours after laser exposure, the concentration of TIMP-1 increased significantly in RPE cells treated with 120mW and 240mW at 24 hours (P=0.006 and P=0.001 respectively) compared with control cells. At 72 hours after treatment, RPE cells treated at 120mW, 240mW and 360mW demonstrated significantly increase in TIMP-1 production compared with control (P=0.003, P < 0.001 and P < 0.001, respectively). No significant reduction in cell viability was observed following laser application as detected by PCNA expression. Conclusions: Our results demonstrated that early TIMP-1 production by RPE cells in cell cultures was enhanced following laser exposure. Eye Science 2005;21:31-37.
出处 《Eye Science》 CAS 2005年第1期31-37,共7页 眼科学报(英文版)
关键词 TIMP-1 视网膜 上皮细胞 激光损伤 免疫细胞学 视色素 tissue inhibitor of metalloproteinases-1 (TIMP-1) retinal pigment epithelium laser cell culture
  • 相关文献

参考文献36

  • 1Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. The second report of diabetic retinopathy study findings. Ophthalmology, 1978 ; 85 : 82-105.
  • 2Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion, a randomised clinical trial. Arch Ophthalmol , 1986; 104:34-41.
  • 3The Central Vein Occlusion Study Group. A randomised clinical trial of early panretinal photocoagulation for ischaemic central vein occlusion. The Central Vein Occlusion Study Group N Report. Ophthalmology, 1995; 102: 1434-1444.
  • 4Kain HL. Chorioretinal adhesion after argon laser photocoagulation. Arch Ophthalmol, 1984; 102:612-615.
  • 5Macular Photocoagulation Study. Argon laser photocoagulation for senile macular degeneration: Results of a randomised clinical trial. Arch Ophthalrrwl,1982; 100:912-918.
  • 6Macular Photocoagulation Study. Argon laser photocoagulation for ocular histoplasmosis: Results of a randomised clinical trial. Arch Ophthcdmol,1985; 101 : 1347-1357.
  • 7Matsumoto M, Yoshimura N, Honda Y. Increased production of transforming growth factor-β2 from cultured human retinal pigment epithelial cells by photocoagulation. Invest Ophthalmol Vis Sci,1994 ; 35 : 4245-4252.
  • 8Ishida K, Yoshimura N, Yoshida M, et al. Upregulation of transforming growth factor-β after panretinal photocoagulation. Invest Ophthalmol Vis Sci, 1998 ; 39 : 801-807.
  • 9Yamamoto C, Ogata N, Yi X, et al. Immunolocalization of transforming growth factor β during wound repair in rat retina after laser photocoagulation. Graefes Arch Clin Exp Ophthalmol, 1998;236:41-46.
  • 10Ogata N, Ando A, Uyama M, et al. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol, 2001 ; 239 : 87-95.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部